Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Live Enterovirus Vaccine and Type 1 Diabetes
NCT02961595Phase 1Completed
- Sponsor
- Tampere University
- Start
- Oct 1999
- Primary completion
- Nov 2016
- Modality
- Live Biotherapeutic Products, Vaccines & Immunotherapeutics
01
Overview
Phase 1, open-label trial of Oral polio vaccine in type 1 diabetes mellitus (T1D) (2 arms), sponsored by Tampere University. Primary endpoint: Number of Participants With the Appearance of Type 1 Diabetes Associated Auto-antibodies in Serum at 11 years. Started Oct 1999; status: completed.
02
Drugs
Oral polio vaccine
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT02961595.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02961595.